Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol

Recruiting Observational Study
Degenerative Spondylolisthesis Lumbar Spinal Stenosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 80
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Beijing Friendship Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

A single-center, prospective cohort trial aims to provide stronger evidence regarding the impact of degenerative spondylolisthesis on the clinical outcome of unilateral biportal endoscopy for lumbar spinal stenosis

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age range: 50-80 years * Diagnosis of LSS affecting 1-2 vertebral levels * Predominant manifestation of neurogenic intermittent claudication, with ineffective conservative treatment for at least 3 months * Presence of lumbar DS of less than grade II and absence of spine instab…
Contacts

Xiang Li

+86 10 6313 9155

muzixiangxin2022@163.com

CONTACT